EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Distinguishing mutants that resist drugs via different mechanisms by examining fitness tradeoffs

Kara Schmidlin iD, Sam Apodaca, Daphne Newell, Alexander Sastokas, Grant Kinsler iD, Kerry Geiler-Samerotte iD

eLife · 10.09.2024 · 13

DOI: 10.7554/elife.94144 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, online erschienen am 10.09.2024. Verfasst von Kara Schmidlin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Biodesign Center for Mechanisms of Evolution, Arizona State University, Tempe, United States. Hauptthemen laut MEDLINE: Fluconazole, Mutation, Saccharomyces cerevisiae, Genetic Fitness. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Science Foundation, Alfred P. Sloan Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is growing interest in designing multidrug therapies that leverage tradeoffs to combat resistance. Tradeoffs are common in evolution and occur when, for example, resistance to one drug results in sensitivity to another. Major questions remain about the extent to which tradeoffs are reliable, specifically, whether the mutants that provide resistance to a given drug all suffer similar tradeoffs. This question is difficult because the drug-resistant mutants observed in the clinic, and even those evolved in controlled laboratory settings, are often biased towards those that provide large fitness benefits. Thus, the mutations (and mechanisms) that provide drug resistance may be more diverse than current data suggests. Here, we perform evolution experiments utilizing lineage-tracking to capture a fuller spectrum of mutations that give yeast cells a fitness advantage in fluconazole, a common antifungal drug. We then quantify fitness tradeoffs for each of 774 evolved mutants across 12 environments, finding these mutants group into classes with characteristically different tradeoffs. Their unique tradeoffs may imply that each group of mutants affects fitness through different underlying mechanisms. Some of the groupings we find are surprising. For example, we find some mutants that resist single drugs do not resist their combination, while others do. And some mutants to the same gene have different tradeoffs than others. These findings, on one hand, demonstrate the difficulty in relying on consistent or intuitive tradeoffs when designing multidrug treatments. On the other hand, by demonstrating that hundreds of adaptive mutations can be reduced to a few groups with characteristic tradeoffs, our findings may yet empower multidrug strategies that leverage tradeoffs to combat resistance. More generally speaking, by grouping mutants that likely affect fitness through similar underlying mechanisms, our work guides efforts to map the phenotypic effects of mutation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FluconazoleMutationSaccharomyces cerevisiaeGenetic FitnessAntifungal AgentsDrug Resistance, Fungal

Stichwörter der Autor:innen

S. cerevisiaeadaptive convergencecollateral sensitivitycomputational biologydrug resistanceevolutionary biologyfitness seascapefitness tradeoffsgenotype-phenotype mapsystems biology

Substanzen

FluconazoleAntifungal Agents

Autor:innen und Institutionen

  • Biodesign Center for Mechanisms of Evolution, Arizona State University, Tempe, United States.
  • School of Life Sciences, Arizona State University, Tempe, United States.
  • Department of Bioengineering, University of Pennsylvania, Philadelphia, United States.

ORCID-Profile: Kara Schmidlin, Grant Kinsler, Kerry Geiler-Samerotte

Förderung

  • NIGMS NIH HHS
  • National Science Foundation
  • Alfred P. Sloan Foundation
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Schmidlin, K., Apodaca, S., Newell, D., Sastokas, A., Kinsler, G., & Geiler-Samerotte, K. (2024). Distinguishing mutants that resist drugs via different mechanisms by examining fitness tradeoffs. eLife, 13. https://doi.org/10.7554/elife.94144

Vancouver

Schmidlin K, Apodaca S, Newell D, Sastokas A, Kinsler G, Geiler-Samerotte K. Distinguishing mutants that resist drugs via different mechanisms by examining fitness tradeoffs. eLife. 2024;13. doi:10.7554/elife.94144

BibTeX
@article{Schmidlin2024,
  author = {Schmidlin, Kara and Apodaca, Sam and Newell, Daphne and Sastokas, Alexander and Kinsler, Grant and Geiler-Samerotte, Kerry},
  title = {Distinguishing mutants that resist drugs via different mechanisms by examining fitness tradeoffs},
  journal = {eLife},
  year = {2024},
  volume = {13},
  doi = {10.7554/elife.94144}
}
Kostenlos starten →